<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3AAngiotensin_II_receptor_blocker%2F31%2Fen</id>
	<title>Translations:Angiotensin II receptor blocker/31/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3AAngiotensin_II_receptor_blocker%2F31%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Angiotensin_II_receptor_blocker/31/en&amp;action=history"/>
	<updated>2026-10-08T21:06:17Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://wiki.tiffa.net/w/index.php?title=Translations:Angiotensin_II_receptor_blocker/31/en&amp;diff=131263&amp;oldid=prev</id>
		<title>FuzzyBot: Importing a new version from external source</title>
		<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Angiotensin_II_receptor_blocker/31/en&amp;diff=131263&amp;oldid=prev"/>
		<updated>2024-03-25T09:03:20Z</updated>

		<summary type="html">&lt;p&gt;Importing a new version from external source&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+ Table 1: Comparison of ARB [[pharmacokinetics]]&lt;br /&gt;
|-&lt;br /&gt;
! Drug&lt;br /&gt;
! Trade name&lt;br /&gt;
! [[Biological half-life]] [hrs]&lt;br /&gt;
! [[Cmax_(pharmacology)|Peak plasma concentration [Tmax] ]]&lt;br /&gt;
! [[Protein binding]] [%]&lt;br /&gt;
! [[Bioavailability]] [%]&lt;br /&gt;
! Renal/hepatic [[Clearance (medicine)|clearance]] [%]&lt;br /&gt;
! Food effect&lt;br /&gt;
! Daily dosage [mg]&lt;br /&gt;
! [[Metabolism]]/[[Transport protein|transporter]]&lt;br /&gt;
|-&lt;br /&gt;
| [[Losartan]]&lt;br /&gt;
| Cozaar&lt;br /&gt;
| 2 h&lt;br /&gt;
| 1 hr &lt;br /&gt;
| 98.7%&lt;br /&gt;
| 33%&lt;br /&gt;
| 10/90%&lt;br /&gt;
| Minimal&lt;br /&gt;
| 50–100&lt;br /&gt;
| [[Sensitive substrates]]: [[CYP2C9]] and [[CYP3A4]]&lt;br /&gt;
|-&lt;br /&gt;
| [[Losartan#Pharmacokinetics|EXP 3174]] active metabolite of losartan&lt;br /&gt;
| -&lt;br /&gt;
| 6–9 hrs&lt;br /&gt;
| 3–4 hrs after oral losartan administration&lt;br /&gt;
| 99.8%&lt;br /&gt;
| –&lt;br /&gt;
| 50/50%&lt;br /&gt;
| –&lt;br /&gt;
| –&lt;br /&gt;
| AUC reduced by phenytoin and rifampin by 63% and 40% respectively; specific CYP450 isozymes are unknown&lt;br /&gt;
|-&lt;br /&gt;
| [[Candesartan]]&lt;br /&gt;
| Atacand&lt;br /&gt;
| 9&lt;br /&gt;
| 3–4 hrs&lt;br /&gt;
| &amp;gt;99%&lt;br /&gt;
| 15%&lt;br /&gt;
| 60/40%&lt;br /&gt;
| No&lt;br /&gt;
| 4–32&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>